# Brimonidine in Rosacea

> **NCT05401422** · NA · UNKNOWN · sponsor: **Cairo University** · enrollment: 45 (estimated)

## Conditions studied

- Rosacea

## Interventions

- **OTHER:** treatment

## Key facts

- **NCT ID:** NCT05401422
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-25
- **Primary completion:** 2022-09-15
- **Final completion:** 2022-09-15
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2022-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05401422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05401422, "Brimonidine in Rosacea". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05401422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*